Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: equality impact assessment - guidance review (PDF 160 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: final appraisal determination information

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: final appraisal determination document (PDF 425 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: evaluation report information

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: evaluation report (PDF 3.82 MB)

Melanoma (previously untreated unresectable stage III or IV) -ipilimumab: Appraisal consultation

Melanoma (previously untreated unresectable stage III or IV): Appraisal consultation document information

Evaluation report information

Evaluation report (PDF 10.56 MB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab: Equality Impact Assessment (PDF 50 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab: response to consultee and commentator comments on the draft scope and provisional matrix (PDF 109 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab: final matrix (PDF 54 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix B - final scope (PDF 54 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix B - final scope (PDF 54 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix C - final matrix (PDF 61 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix D - NICE's response to consultee and commentator comments on the draft scope (PDF 65 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: equality impact assessment (PDF 48 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix A - draft scope (PDF 61 KB)

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab in combination with dacarbazine: appendix B - provisional matrix (PDF 61 KB)